Friday, 23 October 20264:19 pm ISTIndia edition

सच, सीधे आप तक

Book ad space

Just in

Health

MRNA Stock Plunges 18% After Leaked Melanoma Vaccine Data Misses High Hopes

Image: Asianet Newsable. Rights remain with the publisher.

Investors were awaiting full data from the late-stage trial of intismeran autogene plus Merck’s Keytruda at the European Society for Medical Oncology Congress on October 24.

Read the full report on Asianet Newsable

Story file

Section
Health
Topics
Stock market, Health alerts
First reported by
Asianet Newsable
Reporter
stocktwits inc
Published
Friday, 23 October 2026, 3:00 am IST
Coverage
One outlet so far

How this page works. The Headline Update lists this report from Asianet Newsable with a short summary and a link to the original. The original reporting and photograph belong to the publisher. Spotted an error in our summary? Tell our corrections desk.

Related stories

More Health news

See all